APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rifampicin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rifampicin Industry Growth and Trends Forecast to 2032

20 December 202595 pages

Choose your research edition.

Industry ResearchRifampicin Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Rifampicin Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Rifampicin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rifampicin Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Rifampicin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Rifampicin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rifampicin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rifampicin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rifampicin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rifampicin include Sanofi, Hebei Xingang Pharmaceutical, Wellona Pharma, Mercator Pharmaceutical Solutions, AVANSCURE LIFESCIENCES and ASIAN PHARMACY, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rifampicin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rifampicin market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rifampicin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rifampicin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Rifampicin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rifampicin Market by Company

Sanofi

Hebei Xingang Pharmaceutical

Wellona Pharma

Mercator Pharmaceutical Solutions

AVANSCURE LIFESCIENCES

ASIAN PHARMACY

Rifampicin Segment by Type

Oral

Intravenous Injection

Rifampicin Segment by Application

Leprosy

Legionnaire's Disease

Tuberculosis

Others

Rifampicin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rifampicin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rifampicin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rifampicin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rifampicin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Rifampicin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Intravenous Injection Table 3. Global Rifampicin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Rifampicin Sales by Type (2021-2026) & (Tons) Table 5. Global Rifampicin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Rifampicin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Rifampicin Sales Market Share in Value by Type (2021-2026) Table 8. Global Rifampicin Price by Type (2021-2026) & (US$/Ton) Table 9. Global Rifampicin Sales by Type (2027-2032) & (Tons) Table 10. Global Rifampicin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Rifampicin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Rifampicin Sales Market Share in Value by Type (2027-2032) Table 13. Global Rifampicin Price by Type (2027-2032) & (US$/Ton) Table 14. North America Rifampicin Sales by Type (2021-2026) & (Tons) Table 15. North America Rifampicin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Rifampicin Sales by Type (2021-2026) & (Tons) Table 17. Europe Rifampicin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Rifampicin Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Rifampicin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Rifampicin Sales by Type (2021-2026) & (Tons) Table 21. Latin America Rifampicin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Rifampicin Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Rifampicin Sales by Type (2021-2026) & (US$ Million) Table 24. Rifampicin Industry Trends Table 25. Rifampicin Industry Drivers Table 26. Rifampicin Industry Opportunities and Challenges Table 27. Rifampicin Industry Restraints Table 28. Global Rifampicin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Rifampicin Revenue Market Share by Company (2021-2026) Table 30. Global Rifampicin Sales by Company (2021-2026) & (Tons) Table 31. Global Rifampicin Sales Share by Company (2021-2026) Table 32. Global Rifampicin Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Rifampicin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Rifampicin Major Company Production Sites and Headquarters Table 35. Global Rifampicin Company, Product Type & Application Table 36. Global Rifampicin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Rifampicin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Rifampicin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Rifampicin Sales by Region (2021-2026) & (Tons) Table 41. Global Rifampicin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Rifampicin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Rifampicin Sales Market Share in Value by Region (2021-2026) Table 44. Global Rifampicin Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Rifampicin Sales by Region (2027-2032) & (Tons) Table 46. Global Rifampicin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Rifampicin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Rifampicin Sales Market Share in Value by Region (2027-2032) Table 49. Global Rifampicin Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Rifampicin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Rifampicin Sales by Application (2021-2026) & (Tons) Table 52. Global Rifampicin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Rifampicin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Rifampicin Sales Market Share in Value by Application (2021-2026) Table 55. Global Rifampicin Price by Application (2021-2026) & (US$/Ton) Table 56. Global Rifampicin Sales by Application (2027-2032) & (Tons) Table 57. Global Rifampicin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Rifampicin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Rifampicin Sales Market Share in Value by Application (2027-2032) Table 60. Global Rifampicin Price by Application (2027-2032) & (US$/Ton) Table 61. North America Rifampicin Sales by Application (2021-2026) & (Tons) Table 62. North America Rifampicin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Rifampicin Sales by Application (2021-2026) & (Tons) Table 64. Europe Rifampicin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Rifampicin Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Rifampicin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Rifampicin Sales by Application (2021-2026) & (Tons) Table 68. Latin America Rifampicin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Rifampicin Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Rifampicin Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Rifampicin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Sanofi Rifampicin Product Portfolio Table 75. Sanofi Recent Development Table 76. Hebei Xingang Pharmaceutical Company Information Table 77. Hebei Xingang Pharmaceutical Business Overview Table 78. Hebei Xingang Pharmaceutical Rifampicin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Hebei Xingang Pharmaceutical Rifampicin Product Portfolio Table 80. Hebei Xingang Pharmaceutical Recent Development Table 81. Wellona Pharma Company Information Table 82. Wellona Pharma Business Overview Table 83. Wellona Pharma Rifampicin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Wellona Pharma Rifampicin Product Portfolio Table 85. Wellona Pharma Recent Development Table 86. Mercator Pharmaceutical Solutions Company Information Table 87. Mercator Pharmaceutical Solutions Business Overview Table 88. Mercator Pharmaceutical Solutions Rifampicin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Mercator Pharmaceutical Solutions Rifampicin Product Portfolio Table 90. Mercator Pharmaceutical Solutions Recent Development Table 91. AVANSCURE LIFESCIENCES Company Information Table 92. AVANSCURE LIFESCIENCES Business Overview Table 93. AVANSCURE LIFESCIENCES Rifampicin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. AVANSCURE LIFESCIENCES Rifampicin Product Portfolio Table 95. AVANSCURE LIFESCIENCES Recent Development Table 96. ASIAN PHARMACY Company Information Table 97. ASIAN PHARMACY Business Overview Table 98. ASIAN PHARMACY Rifampicin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. ASIAN PHARMACY Rifampicin Product Portfolio Table 100. ASIAN PHARMACY Recent Development Table 101. North America Rifampicin Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 102. North America Rifampicin Sales by Country (2021-2026) & (Tons) Table 103. North America Rifampicin Sales Market Share by Country (2021-2026) Table 104. North America Rifampicin Sales Forecast by Country (2027-2032) & (Tons) Table 105. North America Rifampicin Sales Market Share Forecast by Country (2027-2032) Table 106. North America Rifampicin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Rifampicin Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Rifampicin Market Share by Country (2021-2026) Table 109. North America Rifampicin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Rifampicin Market Share Forecast by Country (2027-2032) Table 111. Europe Rifampicin Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 112. Europe Rifampicin Sales by Country (2021-2026) & (Tons) Table 113. Europe Rifampicin Sales Market Share by Country (2021-2026) Table 114. Europe Rifampicin Sales Forecast by Country (2027-2032) & (Tons) Table 115. Europe Rifampicin Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Rifampicin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Rifampicin Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Rifampicin Market Share by Country (2021-2026) Table 119. Europe Rifampicin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Rifampicin Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Rifampicin Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Rifampicin Sales by Country (2021-2026) & (Tons) Table 123. Asia-Pacific Rifampicin Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Rifampicin Sales Forecast by Country (2027-2032) & (Tons) Table 125. Asia-Pacific Rifampicin Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Rifampicin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Rifampicin Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Rifampicin Market Share by Country (2021-2026) Table 129. Asia-Pacific Rifampicin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Rifampicin Market Share Forecast by Country (2027-2032) Table 131. Latin America Rifampicin Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 132. Latin America Rifampicin Sales by Country (2021-2026) & (Tons) Table 133. Latin America Rifampicin Sales Market Share by Country (2021-2026) Table 134. Latin America Rifampicin Sales Forecast by Country (2027-2032) & (Tons) Table 135. Latin America Rifampicin Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Rifampicin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Rifampicin Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Rifampicin Market Share by Country (2021-2026) Table 139. Latin America Rifampicin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Rifampicin Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Rifampicin Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Rifampicin Sales by Country (2021-2026) & (Tons) Table 143. Middle East and Africa Rifampicin Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Rifampicin Sales Forecast by Country (2027-2032) & (Tons) Table 145. Middle East and Africa Rifampicin Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Rifampicin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Rifampicin Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Rifampicin Market Share by Country (2021-2026) Table 149. Middle East and Africa Rifampicin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Rifampicin Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Rifampicin Distributors List Table 154. Rifampicin Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Rifampicin Image Figure 2. Global Rifampicin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rifampicin Market Size (2021-2032) & (US$ Million) Figure 4. Global Rifampicin Sales (2021-2032) & (Tons) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (Tons) Figure 7. Intravenous Injection Image Figure 8. Global Intravenous Injection Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Rifampicin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Rifampicin Market Share by Type 2025 VS 2032 Figure 11. North America Rifampicin Sales Market Share in Volume by Type in 2025 Figure 12. North America Rifampicin Sales Market Share in Value by Type in 2025 Figure 13. Europe Rifampicin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Rifampicin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Rifampicin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Rifampicin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Rifampicin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Rifampicin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Rifampicin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Rifampicin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Rifampicin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Leprosy Image Figure 24. Global Leprosy Sales YoY Growth (2021-2032) & (Tons) Figure 25. Legionnaire's Disease Image Figure 26. Global Legionnaire's Disease Sales YoY Growth (2021-2032) & (Tons) Figure 27. Tuberculosis Image Figure 28. Global Tuberculosis Sales YoY Growth (2021-2032) & (Tons) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Rifampicin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Rifampicin Market Share by Application 2025 VS 2032 Figure 33. North America Rifampicin Sales Market Share in Volume by Application in 2025 Figure 34. North America Rifampicin Sales Market Share in Value by Application in 2025 Figure 35. Europe Rifampicin Sales Market Share in Volume by Application in 2025 Figure 36. Europe Rifampicin Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Rifampicin Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Rifampicin Sales Market Share in Value by Application in 2025 Figure 39. Latin America Rifampicin Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Rifampicin Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Rifampicin Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Rifampicin Sales Market Share in Value by Application in 2025 Figure 43. North America Rifampicin Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Rifampicin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Rifampicin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Rifampicin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Rifampicin Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Rifampicin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Rifampicin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Rifampicin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Rifampicin Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Rifampicin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Rifampicin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Rifampicin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Rifampicin Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Rifampicin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Rifampicin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Rifampicin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Rifampicin Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Rifampicin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Rifampicin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Rifampicin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Rifampicin Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Rifampicin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Intravenous Injection
Applications
  • Leprosy
  • Legionnaire's Disease
  • Tuberculosis
  • Others
Companies covered
  • Sanofi
  • Hebei Xingang Pharmaceutical
  • Wellona Pharma
  • Mercator Pharmaceutical Solutions
  • AVANSCURE LIFESCIENCES
  • ASIAN PHARMACY

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rifampicin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Rifampicin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Rifampicin Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Intravenous Injection
  8. 1.4 Global Rifampicin Market Size by Type
  9. 1.4.1 Global Rifampicin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Rifampicin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Rifampicin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Rifampicin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Rifampicin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Rifampicin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Rifampicin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Rifampicin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Rifampicin Industry Trends
  2. 2.2 Rifampicin Industry Drivers
  3. 2.3 Rifampicin Industry Opportunities and Challenges
  4. 2.4 Rifampicin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Rifampicin Revenue (2021-2026)
  2. 3.2 Global Top Players by Rifampicin Sales (2021-2026)
  3. 3.3 Global Top Players by Rifampicin Price (2021-2026)
  4. 3.4 Global Rifampicin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rifampicin Major Company Production Sites & Headquarters
  6. 3.6 Global Rifampicin Company, Product Type & Application
  7. 3.7 Global Rifampicin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rifampicin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rifampicin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rifampicin Tier 1, Tier 2, and Tier 3
4 Rifampicin Regional Status and Outlook
  1. 4.1 Global Rifampicin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Rifampicin Historic Market Size by Region
  3. 4.2.1 Global Rifampicin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Rifampicin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Rifampicin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Rifampicin Forecasted Market Size by Region
  7. 4.3.1 Global Rifampicin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Rifampicin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Rifampicin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rifampicin by Application
  1. 5.1 Rifampicin Market by Application
  2. 5.1.1 Leprosy
  3. 5.1.2 Legionnaire's Disease
  4. 5.1.3 Tuberculosis
  5. 5.1.4 Others
  6. 5.2 Global Rifampicin Market Size by Application
  7. 5.2.1 Global Rifampicin Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Rifampicin Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Rifampicin Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Rifampicin Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Rifampicin Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Rifampicin Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Rifampicin Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Rifampicin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Rifampicin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Rifampicin Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Hebei Xingang Pharmaceutical
  8. 6.2.1 Hebei Xingang Pharmaceutical Company Information
  9. 6.2.2 Hebei Xingang Pharmaceutical Business Overview
  10. 6.2.3 Hebei Xingang Pharmaceutical Rifampicin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hebei Xingang Pharmaceutical Rifampicin Product Portfolio
  12. 6.2.5 Hebei Xingang Pharmaceutical Recent Developments
  13. 6.3 Wellona Pharma
  14. 6.3.1 Wellona Pharma Company Information
  15. 6.3.2 Wellona Pharma Business Overview
  16. 6.3.3 Wellona Pharma Rifampicin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Wellona Pharma Rifampicin Product Portfolio
  18. 6.3.5 Wellona Pharma Recent Developments
  19. 6.4 Mercator Pharmaceutical Solutions
  20. 6.4.1 Mercator Pharmaceutical Solutions Company Information
  21. 6.4.2 Mercator Pharmaceutical Solutions Business Overview
  22. 6.4.3 Mercator Pharmaceutical Solutions Rifampicin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mercator Pharmaceutical Solutions Rifampicin Product Portfolio
  24. 6.4.5 Mercator Pharmaceutical Solutions Recent Developments
  25. 6.5 AVANSCURE LIFESCIENCES
  26. 6.5.1 AVANSCURE LIFESCIENCES Company Information
  27. 6.5.2 AVANSCURE LIFESCIENCES Business Overview
  28. 6.5.3 AVANSCURE LIFESCIENCES Rifampicin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AVANSCURE LIFESCIENCES Rifampicin Product Portfolio
  30. 6.5.5 AVANSCURE LIFESCIENCES Recent Developments
  31. 6.6 ASIAN PHARMACY
  32. 6.6.1 ASIAN PHARMACY Company Information
  33. 6.6.2 ASIAN PHARMACY Business Overview
  34. 6.6.3 ASIAN PHARMACY Rifampicin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 ASIAN PHARMACY Rifampicin Product Portfolio
  36. 6.6.5 ASIAN PHARMACY Recent Developments
7 North America by Country
  1. 7.1 North America Rifampicin Sales by Country
  2. 7.1.1 North America Rifampicin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Rifampicin Sales by Country (2021-2026)
  4. 7.1.3 North America Rifampicin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Rifampicin Market Size by Country
  6. 7.2.1 North America Rifampicin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Rifampicin Market Size by Country (2021-2026)
  8. 7.2.3 North America Rifampicin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Rifampicin Sales by Country
  2. 8.1.1 Europe Rifampicin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Rifampicin Sales by Country (2021-2026)
  4. 8.1.3 Europe Rifampicin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Rifampicin Market Size by Country
  6. 8.2.1 Europe Rifampicin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Rifampicin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Rifampicin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Rifampicin Sales by Country
  2. 9.1.1 Asia-Pacific Rifampicin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Rifampicin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Rifampicin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Rifampicin Market Size by Country
  6. 9.2.1 Asia-Pacific Rifampicin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Rifampicin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Rifampicin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Rifampicin Sales by Country
  2. 10.1.1 South America Rifampicin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Rifampicin Sales by Country (2021-2026)
  4. 10.1.3 South America Rifampicin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Rifampicin Market Size by Country
  6. 10.2.1 South America Rifampicin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Rifampicin Market Size by Country (2021-2026)
  8. 10.2.3 South America Rifampicin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Rifampicin Sales by Country
  2. 11.1.1 Middle East and Africa Rifampicin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Rifampicin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Rifampicin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Rifampicin Market Size by Country
  6. 11.2.1 Middle East and Africa Rifampicin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Rifampicin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Rifampicin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Rifampicin Value Chain Analysis
  2. 12.1.1 Rifampicin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Rifampicin Production Mode & Process
  7. 12.2 Rifampicin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Rifampicin Distributors
  10. 12.2.3 Rifampicin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst